schisanhenol b has been researched along with enoxacin in 2 studies
*Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID. [MeSH]
*Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID. [MeSH]
| Studies (schisanhenol b) | Trials (schisanhenol b) | Recent Studies (post-2010) (schisanhenol b) | Studies (enoxacin) | Trials (enoxacin) | Recent Studies (post-2010) (enoxacin) |
|---|---|---|---|---|---|
| 5 | 0 | 3 | 734 | 74 | 122 |
| Protein | Taxonomy | schisanhenol b (IC50) | enoxacin (IC50) |
|---|---|---|---|
| V-type proton ATPase subunit B, brain isoform | Homo sapiens (human) | 10 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 10 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 10 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 10 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 10 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 10 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 10 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, B; Cao, Y; Hu, K; Li, F; Li, R; Li, Y; Ma, X; Peng, H; Peng, T; Sheng, Y; Sun, H; Wang, F; Wang, M; Xi, R; Xiao, W; Zhang, G; Zhang, H; Zhou, Z | 1 |
| He, Y; Hu, K; Li, F; Li, L; Li, S; Liu, W; Lu, X; Ma, X; Peng, H; Peng, T; Sheng, Y; Shi, H; Wang, F; Wang, T; Yu, J; Yuan, Y; Zhang, G; Zhao, Y; Zhou, Z; Zou, J | 1 |
2 other study(ies) available for schisanhenol b and enoxacin
| Article | Year |
|---|---|
Identification of a Novel TAR RNA-Binding Protein 2 Modulator with Potential Therapeutic Activity against Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; DEAD-box RNA Helicases; Enoxacin; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Mice, Nude; MicroRNAs; Polycyclic Compounds; Proteome; Ribonuclease III; RNA-Binding Proteins; Structure-Activity Relationship; Transcriptome; Transplantation, Heterologous | 2021 |
Discovery of a Novel Small-Molecule Inhibitor Disrupting TRBP-Dicer Interaction against Hepatocellular Carcinoma via the Modulation of microRNA Biogenesis.
Topics: Carcinoma, Hepatocellular; Cell Line; DEAD-box RNA Helicases; Humans; Liver Neoplasms; MicroRNAs; Nuclear Receptor Coactivators; Ribonuclease III; RNA-Binding Proteins | 2022 |